Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Apr 23, 2004	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-04-000027.pdf 0001237899-04-000027.xls
Apr 23, 2004	424B3	Form of prospectus reflecting facts events constituting substantive change from last form	View HTML 0000950123-04-005015.pdf 0000950123-04-005015.xls
Apr 23, 2004	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	View HTML 0001206774-04-000384.pdf 0001206774-04-000384.xls
Apr 16, 2004	4/A	Amendment to a previously filed 4	View HTML 0001237899-04-000025.pdf 0001237899-04-000025.xls
Mar 19, 2004	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-04-000023.pdf 0001237899-04-000023.xls
Mar 19, 2004	10-K/A	Amendment to a previously filed 10-K	View HTML 0000950123-04-003550.pdf 0000950123-04-003550.xls
Mar 12, 2004	10-K	Annual report which provides a comprehensive overview of the company for the past year	View HTML 0000950123-04-003254.pdf 0000950123-04-003254.xls
Mar 03, 2004	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-04-000019.pdf 0001237899-04-000019.xls
Mar 03, 2004	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-04-000020.pdf 0001237899-04-000020.xls
Mar 03, 2004	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-04-000021.pdf 0001237899-04-000021.xls

Data provided by Kaleidoscope.

Investors & Media